SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cellegy Pharmaceuticals (CLGY)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: somatics1 who wrote (262)12/30/2002 1:19:38 PM
From: Sergio H  Read Replies (2) of 322
 
Jorge, thanks for joining me in this lonely thread <ggg>.

The low volume, which you mentioned, tells the whole story here. The stock price has been rising since Mr. Gregory started buying shares in Oct. He now owns about 25% of the Co.

As Mr. Gregry has been buying, the volume has been decreasing. Price moving up with lower and lower volume accompanied by major buying indicates that there is less and less shares for sale. There is a nice overhead gap in the mid 6s that is an easy first target, reachable without any news.

News regarding a marketing deal for Tostrex is expected shortly. I expect that this news along with Tostrex winning FDA approval in the Spring will push this stock into the teens.

The action today suggests another Gregory buy accompanied by small sells as has been the case since Oct. The small sells along with the large buy explain the wide price swing with low volume.

A good entry point for someone starting a position would be whatever Gregory's last purchase price was as this has tended to form the new base for the last few months. If you buy, ignore the intraday price swings, sit back an enjoy.

Happy New Year Jorge!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext